Orange Book product · Brand (NDA)
EDARBI
AZILSARTAN KAMEDOXOMIL
Brand (NDA)NDA 200796TE ABRX AZURITY
At a glance
Feb 25, 2011
Approved
Brand (NDA)
Application
AB
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 25, 2011
15 yr 6 mo ago
Today
Patent 9066936 expires
Listed drug product patent expiration.
Mar 26, 2028
in 1 yr 10 mo
Pharmaceutical detail
Active ingredient
AZILSARTAN KAMEDOXOMIL
Strength
EQ 40MG MEDOXOMIL
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 200796
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9066936 | Mar 26, 2028 | in 1 yr 10 mo | Product |
